tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA

Zevra Therapeutics (ZVRA) Technical Analysis

742 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Zevra Therapeutics’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Zevra Therapeutics is a Sell.
Zevra Therapeutics’s (ZVRA) 20-Day exponential moving average is 4.96, while Zevra Therapeutics’s (ZVRA) share price is $6.23, making it a Buy.
Zevra Therapeutics’s (ZVRA) 50-Day exponential moving average is 4.88, while Zevra Therapeutics’s (ZVRA) share price is $6.23, making it a Buy.

Zevra Therapeutics (ZVRA) Pivot Points

Jul 23, 2024, 12:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.16
5.40
5.76
5.99
6.35
6.58
6.94
Fibonacci
5.40
5.63
5.77
5.99
6.22
6.36
6.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Jul 23, 2024, 12:24 PM
Period
Simple
Exponential
MA5
5.51Buy
5.56Buy
MA10
4.99Buy
5.21Buy
MA20
4.79Buy
4.96Buy
MA50
4.78Buy
4.88Buy
MA100
5.19Buy
5.02Buy
MA200
5.16Buy
5.05Buy
Zevra Therapeutics’s (ZVRA) 10-Day exponential moving average is 5.21, while Zevra Therapeutics’s (ZVRA) share price is $6.23, making it a Buy.
Zevra Therapeutics’s (ZVRA) 100-Day exponential moving average is 5.02, while Zevra Therapeutics’s (ZVRA) share price is $6.23, making it a Buy.
Zevra Therapeutics’s (ZVRA) stock price is $6.23 and Zevra Therapeutics’s (ZVRA) 50-day simple moving average is 4.78, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) stock price is $6.23 and Zevra Therapeutics’s (ZVRA) 100-day simple moving average is 5.19, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) stock price is $6.23 and Zevra Therapeutics’s (ZVRA) 200-day simple moving average is 5.16, creating a Buy signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Jul 23, 2024, 12:24 PM
Name
Value
Implied Action
RSI (14)
67.63
Neutral
STOCH (9,6)
82.36
Sell
STOCHRSI (14)
82.36
Sell
MACD (12,26)
0.23
Sell
ADX (14)
23.22
Neutral
Williams %R
-18.72
Sell
CCI (14)
195.35
Sell
ATR (14)
0.34
-
Ultimate Oscillator
56.70
Neutral
ROC
34.17
Buy
Zevra Therapeutics’s (ZVRA) Relative Strength Index (RSI) is 67.63, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Trend Strength Indicator (ADX) is 23.22, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Commodity Channel Index (CCI) is 195.35, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) Price Rate of Change (ROC) is 34.17, creating a Buy signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Buy.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 67.63, which suggests ZVRA is a Neutral.
      What is ZVRA’s MACD?
      ZVRA’s MACD is 0.23, which suggests ZVRA is a Sell.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 5.51, which suggests ZVRA is a Buy.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 4.79, which suggests ZVRA is a Buy.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 4.78, which suggests ZVRA is a Buy.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 5.16, which suggests ZVRA is a Buy.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -18.72, which suggests ZVRA is a Sell.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is 195.35, which suggests ZVRA is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis